Concepedia

Fumihiko Kanzawa

FK

37

Publications

1.6K

Citations

21

H-Index

1969

Active since

Affiliations

National Cancer Research Institute(Current)

National Cancer Centre Japan

Tokyo National Hospital

National Cancer Center Hospital East

National Cancer Center

Fumihiko Kanzawa is an author at National Cancer Research Institute specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1969–2003

37

Publications

37

Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: Characterization and mechanism of resistance

Fumihiko Kanzawa, Yoshikazu Sugimoto, Koichi Minato et al. · Lung Cancer · 1991 · 167 citations

, , +11

Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.

Minoru Fukuda, Kohei Nishio, Fumihiko Kanzawa et al. · PubMed · 1996 · 156 citations

, , +16

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

Y. Ohe, Yusuke Sasaki, Tetsu Shinkai et al. · JNCI Journal of the National Cancer Institute · 1992 · 122 citations

, , +14

Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (“Iressa”) and the DNA topoisomerase I inhibitor CPT‐11 (irinotecan) in human colorectal cancer cells

Fumiaki Koizumi, Fumihiko Kanzawa, Yutaka Ueda et al. · International Journal of Cancer · 2003 · 112 citations

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

Naohiro Kubota, Fumihiko Kanzawa, Kazuto Nishio et al. · Biochemical and Biophysical Research Communications · 1992 · 98 citations

, , +11

Rows per page

1–5 of 37